1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow GREAT Network Italy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adrecizumab Dose Escalation Safety and Tolerability Evaluation (ADESTE) Adrecizumab - Acute Heart Failure | Phase 2 | Unknown | GREAT Network Italy | 30 | 2019-12-15 | 2021-03-09 |
enibarcimab (1)
Indonesia (1)